Phase
Condition
Human Papilloma Virus (Hpv)
Head And Neck Cancer
Nasopharyngeal Cancer
Treatment
COMPLETION OF QUESTIONNAIRES
Clinical Study ID
Ages > 18 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion criteria:
Patient with a histologically proven diagnosis of head and neck squamous cell carcinoma (HNSCC) of the upper aerodigestive tract
Patient whose disease is classified UICC (Union for International Cancer Control (UICC) Tumour, Node, Metastasis (TNM) stage (8th edition): T0-4a NO/N3 M0 (no distant metastasis M0)
Patient World Health Organization (WHO) 0-1-2
Treatment with a feasible curative aim (no contraindication to optimal treatment such as surgery or chemotherapy at a curative dose)
Patient affiliated to a Social Security scheme in France
Patient who did not object to participating in the research.
Non-inclusion criteria:
Patient with a history of previous cervical surgery and/or head and neck irradiation
Pregnant or breastfeeding women
Patient suffering from another co-existing malignant disease at the time of inclusion or any other significant medical (immunosuppression etc.), psychiatric or surgical condition, currently not controlled by treatment, which may interfere with the achievement of the study.
Any psychological, family, geographic or sociological condition that does not allow compliance with medical monitoring and/or the procedures provided for in the study protocol.
Patients deprived of liberty or under legal protection regime (curatorship and guardianship, safeguard of justice).
Study Design
Study Description
Connect with a study center
Chu de Toulouse
Toulouse,
FranceActive - Recruiting

Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.